One year prospective survey of Candida bloodstream infections in Scotland
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
A 12 month survey of candidaemia in Scotland, UK, in which every Scottish hospital laboratory submitted all blood isolates of yeasts for identification, strain typing and susceptibility testing, provided 300 isolates from 242 patients, generating incidence data of 4.8 cases per 100 000 population per year and 5.9 cases per 100 000 acute occupied bed days; 27.9 % of cases occurred in intensive care units. More than half the patients with candidaemia had an underlying disease involving the abdomen, 78 % had an indwelling intravenous catheter, 62 % had suffered a bacterial infection within the 2 weeks prior to candidaemia and 37 % had undergone a laparotomy.Candida albicans was the infecting species in 50 % of cases, followed by Candida glabrata(21 %) and Candida parapsilosis(12 %). Seven cases of candidaemia were caused by Candida dubliniensis, which was more prevalent even than Candida lusitaniae and Candida tropicalis(six cases each). Among C. glabrata isolates, 55 % showed reduced susceptibility to fluconazole, but azole resistance among other species was extremely low. Multilocus sequence typing showed isolates with high similarity came from different hospitals across the country, and many different types came from the hospitals that submitted the most isolates, indicating no tendency towards hospital-specific endemic strains. Multiple isolates of C. albicans and C. glabrata from individual patients were of the same strain type with single exceptions for each species. The high prevalence of candidaemia in Scotland, relative to other population-based European studies, and the high level of reduced fluconazole susceptibility of Scottish C. glabrata isolates warrant continued future surveillance of invasive Candida infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Scotland had a rate of candidaemia of 4.8 cases per 100,000 population per year shortly after the millennium, 254 bloodstream and 669 invasive Candida cases annually [27].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [27]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Feil, E. J., Li, B. C., Aanensen, D. M., Hanage, W. P., & Spratt, B. G. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.5.1518-1530.2004 · Cited by 1,861 · cited 2×
“Relatedness of C. albicans isolates that differed from each other in only one of the seven MLST gene loci was determined by eBURST analysis (Feil et al., 2004) and isolates found to be related by this analysis were referred to as clonal clusters.”
MethodGuidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 1×
“The most recent recommendations for treatment of candidaemia include removal of IV catheters (this was done in 77 % of our catheterized patients) as well as systemic antifungal therapy (Pappas et al., 2004).”
BackgroundReference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard
Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,052
Blumberg, H. M., Jarvis, W. R., Soucie, J. M., Edwards, J. E., Patterson, J. E., Pfaller, M. A., Rangel‐Frausto, M. S., Rinaldi, M. G., Saiman, L., Wiblin, R. T., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/321811 · Cited by 661 · cited 2×
“98 described by Blumberg et al. (2001). The differences in cases per occupied ICU bed day may be explained by differences in illness severity.”
BackgroundResultInfluentialTrick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997
McNeil, M. M., Nash, S. L., Hajjeh, R. A., Phelan, M. A., Conn, L. A., Plikaytis, B. D., & Warnock, D. W. (2001) · Clinical Infectious Diseases · doi:10.1086/322606 · Cited by 657
Hajjeh, R. A., Sofair, A. N., Harrison, L. H., Lyon, G. M., Arthington-Skaggs, B. A., Mirza, S. A., Phelan, M., Morgan, J., Lee-Yang, W., Ciblak, M. A., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.4.1519-1527.2004 · Cited by 649 · cited 11×
“…in incidence, with an estimated 6 cases per 105 population in Iowa (Diekema et al., 2002), 7 cases per 105 population in Connecticut (Hajjeh et al., 2004), 8 cases per 105 population in Atlanta and San Francisco (Kao et al., 1999), and 24 cases per 105 population in Baltimore…”
BackgroundInfluentialOdds, F. C., & Bernaerts, R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.8.1923-1929.1994 · Cited by 629 · cited 2×
“The isolates received were streaked to single colonies on CHROMagar Candida plates to facilitate detection of mixed cultures, and provide presumptive identification of C. albicans/Candida dubliniensis, C. krusei and C. tropicalis (Odds & Bernaerts, 1994).”
BackgroundSelf-citationTavanti, A., Davidson, A. D., Gow, N. A. R., Maiden, M. C. J., & Odds, F. C. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.284-292.2005 · Cited by 593 · cited 6×
“Isolates of C. albicans, C. glabrata and C. tropicalis were further characterized by MLST (Bougnoux et al., 2003; Dodgson et al., 2003; Tavanti et al., 2005c).”
BackgroundMethodInfluentialSelf-citationAlmirante, B., Rodríguez, D., Park, B. J., Cuenca-Estrella, M., Planes, A. M., Almela, M., Mensa, J., Sanchez, F., Ayats, J., Gimenez, M., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.4.1829-1835.2005 · Cited by 566 · cited 1×
“Recent surveys of candidaemia from Spain and Italy have shown prevalences of C. parapsilosis between 20 and 40 % (Almirante et al., 2005; Cuenca-Estrella et al., 2002a; Marco et al., 2003; Pemán et al., 2005; San Miguel et al., 2005).”
Background
Research works printed but not linked: 1
- 2004, Candidaemia reports, England, Wales, and Northern Ireland: 2003, CDR Weekly, 14, 1
Cited by
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
“The occurrence of disseminated Candida infections has been surveyed frequently in the United States and in many European countries, and variable reported incidences ranging from 2.4 (Norway) to 29 cases (Iowa, United States) per 100,000 inhabitants have been published ( 14 – 23 ).”
InfluentialSelf-citationGlobal and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
“8 cases per 100,000 population per year shortly after the millennium, 254 bloodstream and 669 invasive Candida cases annually [27].”
BackgroundChanges in the epidemiological landscape of invasive candidiasis
Lamoth, F., Lockhart, S. R., Berkow, E. L., & Calandra, T. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx444 · Cited by 547
Changing epidemiology of systemic fungal infections
Richardson, M., & Lass-Flörl, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01978.x · Cited by 524
“Of note is the emergence of Candida dubliniensis in some centres [107].”
BackgroundAntifungal drug resistance among Candida species: mechanisms and clinical impact
Sanguinetti, M., Posteraro, B., & Lass‐Flörl, C. (2015) · Mycoses · doi:10.1111/myc.12330 · Cited by 394
Epidemiology of invasive candidiasis
Arendrup, M. C. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e84d2 · Cited by 376
Falagas, M. E., Roussos, N., & Vardakas, K. Z. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.04.006 · Cited by 346
“, 2007 [33] Prospective, 2005–2006, 19 tertiary hospitals in Scotland 4.”
Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis
Koehler, P., Stecher, M., Cornely, O. A., Koehler, D., Vehreschild, M. J. G. T., Bohlius, J., Wisplinghoff, H., & Vehreschild, J. J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.024 · Cited by 336
Population-Based Epidemiology and Microbiology of Community-Onset Bloodstream Infections
Laupland, K. B., & Church, D. L. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-14 · Cited by 323
Lockhart, S. R., Iqbal, N., Cleveland, A. A., Farley, M. M., Harrison, L. H., Bolden, C. B., Baughman, W., Stein, B., Hollick, R., Park, B. J., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01283-12 · Cited by 299
“glabrata candidemia at or above 20% (2, 9, 19, 28, 29, 33).”
Rajendran, R., Sherry, L., Nile, C. J., Sherriff, A., Johnson, E. M., Hanson, M. F., Williams, C., Munro, C. A., Jones, B. J., & Ramage, G. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.09.018 · Cited by 228
“8 cases per 100 000 population per year) [15].”
BackgroundSelf-citationNational Surveillance of Fungemia in Denmark (2004 to 2009)
Arendrup, M. C., Bruun, B., Christensen, J. J., Fuursted, K., Johansen, H. K., Kjældgaard, P., Knudsen, J. D., Kristensen, L., Møller, J., Nielsen, L., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01811-10 · Cited by 223
“0/100,000 have been reported (3, 9, 30, 33, 49), with 56% (43 to 67%) of the cases being caused by C.”
Bruder-Nascimento, A., Camargo, C., Sugizaki, M., Sadatsune, T., Montelli, A., Mondelli, A., & Bagagli, E. (2010) · BMC Research Notes · doi:10.1186/1756-0500-3-1 · Cited by 221
“parapsilosis is controversial since most studies report a lack of amphotericin B resistance in Candida species [2,20,26], while other studies also found resistance to this drug in C.”
BackgroundEpidemiology of candidaemia and invasive candidiasis. A changing face
Quindós, G. (2014) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.10.001 · Cited by 219
Tissari, P., Zumla, A., Tarkka, E., Mero, S., Savolainen, L., Vaara, M., Aittakorpi, A., Laakso, S., Lindfors, M., Piiparinen, H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61569-5 · Cited by 219
Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans
Jackson, A. P., Gamble, J. A., Yeomans, T., Moran, G. P., Saunders, D., Harris, D., Aslett, M., Barrell, J. F., Butler, G., Citiulo, F., et al. (2009) · Genome Research · doi:10.1101/gr.097501.109 · Cited by 215
“However, while C. albicans causes ;50%–60% of cases of systemic candidosis, C. dubliniensis is not usually associated with haematogenous infection and accounts for only ;2%–3% of Candida species recovered from blood samples (Kibbler et al. 2003; Odds et al. 2007).”
BackgroundSelf-citationArendrup, M. C., Dzajic, E., Jensen, R. H., Johansen, H. K., Kjaldgaard, P., Knudsen, J. D., Kristensen, L., Leitz, C., Lemming, L. E., Nielsen, L., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12212 · Cited by 206
Lockhart, S. R., Messer, S. A., Pfaller, M. A., & Diekema, D. J. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00803-08 · Cited by 206
Arendrup, M. C., Garcia-Effron, G., Lass-Flörl, C., Lopez, A. G., Rodriguez-Tudela, J.-L., Cuenca-Estrella, M., & Perlin, D. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01256-09 · Cited by 158
“They are among the preferred agents for invasive candidiasis, as a number of recent fungemia surveys have reported a considerable proportion of cases involving species with reduced susceptibility to fluconazole (3, 4, 24, 28, 31, 37, 44).”
BackgroundTortorano, A. M., Dho, G., Prigitano, A., Breda, G., Grancini, A., Emmi, V., Cavanna, C., Marino, G., Morero, S., Ossi, C., et al. (2012) · Mycoses · doi:10.1111/j.1439-0507.2011.02044.x · Cited by 140
Multilocus Sequence Typing of Pathogenic Candida Species
Odds, F. C., & Jacobsen, M. D. (2008) · Eukaryotic Cell · doi:10.1128/ec.00062-08 · Cited by 138
“albicans isolates were typed by MLST, indistinguishable DSTs were found for some bloodstream isolates from hospitals in different cities (46).”
Self-citationDas, I., Nightingale, P., Patel, M., & Jumaa, P. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.06.006 · Cited by 137
Candida albicans versus Candida dubliniensis: Why Is C. albicans More Pathogenic?
Moran, G. P., Coleman, D. C., & Sullivan, D. J. (2012) · International Journal of Microbiology · doi:10.1155/2012/205921 · Cited by 128
“Taken together, these data suggest that C. dubliniensis is in the process of undergoing reductive evolution and may have become adapted for growth in a specialized anatomic niche.”
BackgroundAstvad, K. M. T., Johansen, H. K., Røder, B. L., Rosenvinge, F. S., Knudsen, J. D., Lemming, L., Schønheyder, H. C., Hare, R. K., Kristensen, L., Nielsen, L., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01564-17 · Cited by 125
Arendrup, M. C., Garcia-Effron, G., Buzina, W., Mortensen, K. L., Reiter, N., Lundin, C., Jensen, H. E., Lass-Flörl, C., Perlin, D. S., & Bruun, B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01292-08 · Cited by 123
“This is a consequence of a number of recent fungemia surveys reporting a considerable proportion of cases involving species with reduced susceptibility to fluconazole, such as Candida glabrata and Candida krusei (3, 22, 31, 42, 47).”
BackgroundDrgona, L., Khachatryan, A., Stephens, J., Charbonneau, C., Kantecki, M., Haider, S., & Barnes, R. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1944-3 · Cited by 126
“2) [14–88].”
Oberoi, J. K., Wattal, C., Goel, N., Raveendran, R., Datta, S., & Prasad, K. (2012) · PubMed Central · Cited by 154
Estimating the burden of invasive and serious fungal disease in the United Kingdom
Pegorie, M., Denning, D. W., & Welfare, W. (2017) · Journal of Infection · doi:10.1016/j.jinf.2016.10.005 · Cited by 104
Asmundsdottir, L. R., Erlendsdottir, H., & Gottfredsson, M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02566-12 · Cited by 100
Twenty-two years of candidaemia surveillance: results from a Norwegian national study
Hesstvedt, L., Gaustad, P., Andersen, C. T., Haarr, E., Hannula, R., Haukland, H. H., Hermansen, N. O., Larssen, K. W., Mylvaganam, H., Ranheim, T. E., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.06.008 · Cited by 101
Pannanusorn, S., Fernandez, V., & Römling, U. (2012) · Mycoses · doi:10.1111/myc.12014 · Cited by 110
Rajendran, R., Sherry, L., Deshpande, A., Johnson, E. M., Hanson, M. F., Williams, C., Munro, C. A., Jones, B. L., & Ramage, G. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00915 · Cited by 81
“This data is comparable to those of 2005/06 (4.8 cases per 100,000 of population per year) (Odds et al., 2007).”
BackgroundResultInfluentialSelf-citationJensen, R. H., Johansen, H. K., Søes, L. M., Lemming, L. E., Rosenvinge, F. S., Nielsen, L., Olesen, B., Kristensen, L., Dzajic, E., Astvad, K. M. T., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01763-15 · Cited by 77
“glabrata isolates, despite no geographical or historical link, but again, this can probably be ascribed to the low discriminatory power rather than to clonal expansion (41, 42).”
BackgroundSpiering, M. J., Moran, G. P., Chauvel, M., MacCallum, D. M., Higgins, J., Hokamp, K., Yeomans, T., d'Enfert, C., Coleman, D. C., & Sullivan, D. J. (2010) · Eukaryotic Cell · doi:10.1128/ec.00291-09 · Cited by 77
“albicans, as judged by differences in carriage rates and prevalence in the human host (7, 27, 28, 45) and by differences in virulence in vitro and in murine infection models (8, 12, 23, 41).”
BackgroundExcess mortality, length of stay and cost attributable to candidaemia
Hassan, I., Powell, G., Sidhu, M., Hart, W. M., & Denning, D. W. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.08.020 · Cited by 88
Yu, Q., Zhang, B., Lǐ, J., Zhang, B., Wang, H., & Li, M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.09.014 · Cited by 78
Shin, J. H., Bougnoux, M.-E., d'Enfert, C., Kim, S. H., Moon, C.-J., Joo, M. Y., Lee, K., Kim, M.-N., Lee, H. S., Shin, M. G., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02153-10 · Cited by 69
“albicans BSI isolates from different hospitals (2, 13).”
BackgroundCandida dubliniensis: An Appraisal of Its Clinical Significance as a Bloodstream Pathogen
Khan, Z., Ahmad, S., Joseph, L., & Chandy, R. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032952 · Cited by 73
“isolates (Table S1) [6,10,24–42].”
Wille, M. P., Guimarães, T., Furtado, G. H. C., & Colombo, A. L. (2013) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762013000300005 · Cited by 75
“…Inst Oswaldo Cruz, Rio de Janeiro, Vol. 108(2): 288-292, April 2013 Bloodstream infections (BSI) caused by Candida species are an important cause of morbidity and mortality in hospitalised patients worldwide (Zaoutis et al. 2005, Odds et al. 2007, Pfaller & Diekema 2007, Hsueh & Ruan 2009).”
BackgroundEmergence and evolution of virulence in human pathogenic fungi
Siscar-Lewin, S., Hube, B., & Brunke, S. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2021.12.013 · Cited by 75
Farooqi, J. Q., Jabeen, K., Saeed, N., Iqbal, N., Malik, B., Lockhart, S. R., Zafar, A., Brandt, M. E., & Hasan, R. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.048785-0 · Cited by 63
“…USA, Europe, South America and the Far East, which have reported C. albicans as the most common species (Colombo et al., 2006; Falagas et al., 2010; Odds et al., 2007), with the most frequent non-C. albicans species being either C. parapsilosis in Southern Europe and South America or C. glabrata…”
BackgroundWattal, C., Raveendran, R., Goel, N., Oberoi, J. K., & Rao, B. K. (2014) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2013.07.010 · Cited by 62
Whibley, N., MacCallum, D. M., Vickers, M. A., Zafreen, S., Waldmann, H., Hori, S., Gaffen, S. L., Gow, N. A. R., Barker, R. N., & Hall, A. M. (2014) · European Journal of Immunology · doi:10.1002/eji.201343604 · Cited by 60
Self-citationLott, T. J., Frade, J. P., & Lockhart, S. R. (2010) · Eukaryotic Cell · doi:10.1128/ec.00002-10 · Cited by 58
“A total of 230 incident bloodstream isolates from population-based surveillance in the United States were typed using MLST.”
BackgroundInfluentialMacCallum, D. M. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00576.x · Cited by 56
“Systemic fungal infections remain a significant cause of morbidity and mortality, with Candida albicans being the most common causative agent (Odds et al., 2007; Bougnoux et al., 2008; Caggiano et al., 2008; Playford et al., 2008).”
BackgroundCuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.2 · Cited by 59
Rare and emerging Candida species
Johnson, E. M. (2009) · Current Fungal Infection Reports · doi:10.1007/s12281-009-0020-z · Cited by 57
“Although new species, these cannot be considered as emerging pathogens in the true sense because examination of culture collections going back for several decades has revealed C. dubliniensis amongst isolates stored as C. albicans [15], and the same is true for the cryptic sister species of C. parapsilosis [ 16 ].”
BackgroundInfluentialLiposomal Amphotericin B Displays Rapid Dose-Dependent Activity against Candida albicans Biofilms
Ramage, G., Jose, A., Sherry, L., Lappin, D. F., Jones, B., & Williams, C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02344-12 · Cited by 55
“albicans bloodstream strains 62 obtained from a Scottish candidaemia study were selected for testing (10).”
MethodSelf-citationTumbarello, M., Sanguinetti, M., Trecarichi, E. M., La Sorda, M., Rossi, M., de Carolis, E., de Gaetano Donati, K., Fadda, G., Cauda, R., & Posteraro, B. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn381 · Cited by 53
“Interventions that affect the intestine are highly likely to create a conduit for yeast to enter the bloodstream.(39) The association between surgical procedures involving the bowel and fungaemia caused by FS strains can be explained either by greater fitness of the FS strains(40) or by local factors in our hospital.”
BackgroundHegazi, M., Abdelkader, A., Zaki, M., & El-Deek, B. (2014) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.4186 · Cited by 50
“krusei isolates [22,25].”
An Introduction to the Medically Important Candida Species
Moran, G., Coleman, D., & Sullivan, D. (2014) · Candida and Candidiasis · doi:10.1128/9781555817176.ch2 · Cited by 40
Vazquez, J. A., Patton, L. L., Epstein, J. B., Ramlachan, P., Mitha, I. H., Noveljic, Z., Fourie, J., Conway, B., Lalla, R. V., Barasch, A., et al. (2010) · HIV Clinical Trials · doi:10.1310/hct1104-186 · Cited by 48
Candida identification: a journey from conventional to molecular methods in medical mycology
Alam, M. Z., Alam, Q., Jiman-Fatani, A. A., Kamal, M. A., Abuzenadah, A. M., Chaudhary, A., Akram, M., & Haque, A. (2014) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-013-1574-z · Cited by 57
“MLST data for C. albicans strains are available in a public database that provides an indispensable resource to evaluate the worldwide diversity of C. albicans and the relationships of isolates identified at various locations (Odds et al. 2007; Tavanti et al. 2005).”
BackgroundGe, S.-H., Xie, J., Xu, J., Li, J., Li, D., Zong, L., Zheng, Y., & Bai, F. (2011) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2011.10.006 · Cited by 44
Yu, Q., Ding, X., Zhang, B., Xu, N., Jia, C., Mao, J., Zhang, B., Xing, L., & Li, M. (2014) · FEMS Yeast Research · doi:10.1111/1567-1364.12150 · Cited by 44
Enjalbert, B., Moran, G. P., Vaughan, C., Yeomans, T., MacCallum, D. M., Quinn, J., Coleman, D. C., Brown, A. J. P., & Sullivan, D. J. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06640.x · Cited by 42
“(Kibbler et al., 2003; Sullivan et al., 2004; Odds et al., 2007).”
Berdal, J., Haagensen, R., Ranheim, T. E., & Bjørnholt, J. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103916 · Cited by 46
“Patients undergoing multiple abdominal surgery, suffering from haematological malignancies, or residing in ICU’s are recognized risk groups [10,13], but otherwise data on the intra-hospital epidemiology of candidemia is scarce.”
BackgroundResultAlkharashi, N., AlJohani, S. M., Layqah, L. A., Masuadi, E., Baharoon, W., Al-Jahdali, H. H., & Baharoon, S. A. (2019) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2019/2015692 · Cited by 51
Candida albicans Forms a Specialized “Sexual” as Well as “Pathogenic” Biofilm
Park, Y., Daniels, K. J., Pujol, C., Srikantha, T., & Soll, D. R. (2013) · Eukaryotic Cell · doi:10.1128/ec.00112-13 · Cited by 41
AFLP genotyping of Candida metapsilosis clinical isolates: Evidence for recombination
Hensgens, L. A. M., Tavanti, A., Mogavero, S., Ghelardi, E., & Senesi, S. (2009) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.06.006 · Cited by 39
Development of echinocandin resistance in Clavispora lusitaniae during caspofungin treatment.
Desnos-Ollivier, M., Moquet, O., Chouaki, T., Guérin, A.-M., & Dromer, F. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00325-11 · Cited by 37
“6 to 2% of the isolates recovered during candidemia (12, 18, 23).”
BackgroundSpreghini, E., Orlando, F., Sanguinetti, M., Posteraro, B., Giannini, D., Manso, E., & Barchiesi, F. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05872-11 · Cited by 37
“Candida glabrata has recently been reported to be the second most common cause of invasive candidiasis, and there are increasing amounts of data showing its important role in determining either superficial or deep-seated infections (4, 18).”
BackgroundSchelenz, S., Barnes, R. A., Kibbler, C. C., Jones, B., & Denning, D. W. (2009) · Journal of Infection · doi:10.1016/j.jinf.2008.12.006 · Cited by 38
Self-citationChalmers, C., Gaur, S., Chew, J., Wright, T., Kumar, A., Mathur, S., Wan, W. Y., Gould, I. M., Leanord, A., & Bal, A. M. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02027.x · Cited by 35
Gligorov, J., Bastit, L., Gervais, H., Henni, M., Kahila, W., Lepille, D., Luporsi, É., Sasso, G., Varette, C., & Azria, D. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.02.006 · Cited by 42
Gorton, R., Ramnarain, P., Barker, K. R., Stone, N. R. H., Rattenbury, S., McHugh, T. D., & Kibbler, C. C. (2014) · Mycoses · doi:10.1111/myc.12205 · Cited by 37
Galia, L., Pezzani, M. D., Compri, M., Callegari, A., Rajendran, N. B., Carrara, E., Tacconelli, E., & the COMBACTE MAGNET EPI-Net Network (2022) · Journal of Fungi · doi:10.3390/jof8030249 · Cited by 38
Bonfietti, L. X., Szeszs, M. W., Chang, M. R., Martins, M. A., Pukinskas, S. R. B. S., Nunes, M. O., Pereira, G. H., Paniago, A. M. M., Purisco, S. U., & Melhem, M. D. S. C. (2012) · Mycopathologia · doi:10.1007/s11046-012-9566-3 · Cited by 37
“[11] found up to 3 % of candidemia causative agents were C.”
BackgroundAsadzadeh, M., Ahmad, S., Al‐Sweih, N., & Khan, Z. (2018) · Medical Principles and Practice · doi:10.1159/000493426 · Cited by 33
Zuo, X., Liu, Y., Cai, X., Zhan, L., & Hu, K. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23738 · Cited by 40
The Epidemiology of Invasive Candidiasis
Pfaller, M. A., & Diekema, D. J. (2014) · Candida and Candidiasis · doi:10.1128/9781555817176.ch29 · Cited by 33
Fungal Diagnostics: Review of Commercially Available Methods
Marcos, J. Y., & Pincus, D. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-257-5_2 · Cited by 34
Magri, M. M. C., Gomes‐Gouvêa, M. S., de Freitas, V. L. T., Motta, A. L., Moretti, M. L., & Shikanai‐Yasuda, M. A. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.02366-12 · Cited by 35
“According to previous studies, variations in the isolates from the same patient could be explained by cross-contamination during the transport and storage times (33) or by polymorphisms that are related to antifungal-drug use (52).”
Tsai, M.-H., Wang, S.-H., Hsu, J., Lin, L.-C., Chu, S., Huang, H.-R., Chiang, M., Fu, R.-H., Lu, J., & Huang, Y. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.06.024 · Cited by 32
“Although MLST has been proven superior to PFGE and at least compa rable to Southern hybridization [43,44], a strict definition of a nosocomial cluste r as those occurring within a period of 90 days [18] would make the cluster identificati on more effective and reliable.”
BackgroundMethodÁsmundsdóttir, L. R., Erlendsdóttir, H., Agnarsson, B. A., & Gottfreðsson, M. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02840.x · Cited by 33
“dubliniensis has been increasingly reported [7–9] in patients with a wide variety of underlying diseases [10–15].”
BackgroundKatragkou, A., Roilides, E., & Walsh, T. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ746 · Cited by 35
“Catheters provide the surface for a microorganism to colonize and form biofilms [60].”
BackgroundAmanloo, S., Shams-Ghahfarokhi, M., Ghahri, M., & Razzaghi-Abyaneh, M. (2018) · Medical Mycology · doi:10.1093/mmy/myx030 · Cited by 30
Epidemiology of Candidemia in Kuwait: A Nationwide, Population-Based Study
Alobaid, K., Ahmad, S., Asadzadeh, M., Mokaddas, E. M., Al‐Sweih, N., Benwan, K. A., Alfouzan, W. A., Al‐Obaid, I., Jeragh, A., Al-Roomi, E., et al. (2021) · Journal of Fungi · doi:10.3390/jof7080673 · Cited by 35
“9 cases per 100,000 inhabitants among the elderly (≥65 years old), which is comparable to Kuwait [62].”
Candida profiles and antifungal resistance evolution over a decade in Lebanon
Araj, G. F., Asmar, R. G., & Avedissian, A. Z. (2015) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.6550 · Cited by 33
“5% [3,39,40].”
Candida Infections and Modelling Disease
MacCallum, D. M. (2009) · Springer eBooks · doi:10.1007/978-3-642-03150-2_3 · Cited by 33
Grumaz, C., Lorenz, S., Stevens, P., Lindemann, E., Schöck, U., Retey, J., Rupp, S., & Sohn, K. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-212 · Cited by 34
“dubliniensis seems to be far less successful in colonizing the human host causing systemic candidiases [6-8].”
Lovero, G., Borghi, E., Balbino, S., Cirasola, D., Giglio, O. D., Perdoni, F., Caggiano, G., Morace, G., & Montagna, M. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150218 · Cited by 31
“metapsilosis candidemia, in keeping with studies performed in Portugal [23], Qatar [22], Scotland [24], and Kuwait [25].”
ResultHelmstetter, N., Chybowska, A. D., Delaney, C., Dantas, A. D. S., Gifford, H., Wacker, T., Munro, C. A., Warris, A., Jones, B. L., Cuomo, C. A., et al. (2022) · Genetics · doi:10.1093/genetics/iyac031 · Cited by 33
“…C. glabrata have also exhibited alarming increases in resistance against all major classes of antifungal drugs, hindering effective treatments and resulting in increasing mortality rates (Cowen et al. 2002; Odds et al. 2007; Pfaller et al. 2012; Rajendran et al. 2016a; Barber et al. 2019).”
Self-citationNeoh, C. F., Slavin, M. A., Chen, S. C. ‐., Stewart, K., & Kong, D. C. M. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.08.010 · Cited by 33
Lott, T. J., Frade, J. P., Lyon, G. M., Iqbal, N. J., & Lockhart, S. R. (2012) · Medical Mycology · doi:10.3109/13693786.2011.592153 · Cited by 35
Tan, T. Y., Tan, A. L., Tee, N. W. S., Ng, L. S. Y., & Chee, C. W. J. (2010) · Mycoses · doi:10.1111/j.1439-0507.2009.01746.x · Cited by 28
Silva, L. N., de Mello, T. P., Ramos, L. S., Branquinha, M. H., & dos Santos, A. L. S. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191025152412 · Cited by 29
Yi, Q., Xiao, M., Fan, X., Zhang, G., Yang, Y., Zhang, J., Duan, S., Cheng, J., Li, Y., Zhou, M., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.628828 · Cited by 51
“Within less than a decade, the introduction of MALDI-TOF MS has enabled rapid and accurate identification of microorganisms including bacteria, mycobacteria, yeasts and filamentous fungi in clinical laboratories (Odds et al., 2007; Rychert et al., 2018) Autof MS 1000 (Autobio Diagnostics, Zhengzhou, China), a commerci…”
BackgroundGong, Y., Zheng, J.-L., Jin, B., Zhuo, D., Huang, Z.-Q., Qi, H., Zhang, W., Duan, W., Fu, J.-T., Chui-jie, W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035311 · Cited by 27
Wu, J., Guo, H., Wang, H.-M., Yi, G., Zhou, L., He, X., Zhang, Y., & Xu, J. (2017) · Scientific Reports · doi:10.1038/srep42537 · Cited by 29
Böttcher, B., Palige, K., Jacobsen, I. D., Hube, B., & Brunke, S. (2015) · Eukaryotic Cell · doi:10.1128/ec.00078-15 · Cited by 35
Environmental and genetic regulation of white‐opaque switching in Candida tropicalis
Zheng, Q., Zhang, Q., Bing, J., Ding, X., & Huang, G. (2017) · Molecular Microbiology · doi:10.1111/mmi.13862 · Cited by 26
Surveillance study of candidemia in cancer patients in North China
Li, D., Zhang, W., Zheng, S., Ma, Z., Zhang, P., & Liu, Z. (2012) · Medical Mycology · doi:10.3109/13693786.2012.727481 · Cited by 23
Yue, H., Hu, J., Guan, G., Li, T., Du, H., Li, H., & Huang, G. (2015) · Virulence · doi:10.1080/21505594.2015.1135287 · Cited by 23
Dostál, J., Brynda, J., Hrušková‐Heidingsfeldová, O., Sieglová, I., Pichová, I., & Řezáčová, P. (2009) · Journal of Structural Biology · doi:10.1016/j.jsb.2009.04.004 · Cited by 23
“Nevertheless, C. parapsilosis ranks as the second or the third most common cause of Candida bloodstream infections in studies performed in Europe, Canada, and Latin America (Caggiano et al., 2008; Colombo et al., 2006; Costa-de-Oliveira et al., 2008; Odds et al., 2007; Pfaller et al., 2008).”
BackgroundPektaş, A., Kara, A., & Gürgey, A. (2015) · Turkish Journal of Hematology · doi:10.4274/tjh.2013.0403 · Cited by 24
“Coagulase-negative staphylococci are responsible for the majority of catheter-related bloodstream infections, whereas gram-negative bacteria, enterococci, and Candida species account for the remainder of these infections [12,16].”
BackgroundEl-Abiary, M., Jones, B. L., Williams, G. J., & Lockington, D. (2018) · Eye · doi:10.1038/s41433-018-0160-x · Cited by 22
Self-citationMolecular Typing of Candida glabrata
Gabaldón, T., Gómez-Molero, E., & Bader, O. (2019) · Mycopathologia · doi:10.1007/s11046-019-00388-x · Cited by 26
Schaefer, S., Melodia, D., Pracey, C. P., Corrigan, N. A., Lenardon, M. D., & Boyer, C. A. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.3c01038 · Cited by 21
Geographic Trends in Invasive Candidiasis
Nishikaku, A. S., Melo, A. S. D. A., & Colombo, A. L. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0033-7 · Cited by 24
“Scotland 228 2005−2006 [21] 53.”
Metadata
- Authors
- Odds, F. C., Hanson, M. F., Davidson, A. D., Jacobsen, M. D., Wright, P., Whyte, J. A., Gow, N. A. R., & Jones, B. L.
- Affiliations
- University of Aberdeen (GB)
- Western General Hospital (GB)
- Glasgow Royal Infirmary (GB)
- Venue
- Journal of Medical Microbiology
- Publisher
- Microbiology Society
- Published
- 2007-08-01
- Volume
- 56
- Issue
- 8
- Pages
- 1066-1075
- ISSN
- 0022-2615 (ISSN-L)
- 1473-5644
- PMC
- PMC2884937
- OpenAlex
- W2165403985
- Semantic Scholar
- 9ce27f081fa0bd39c9dc33b36b53081b5f8a01f9
- Cited by
- 176
- References
- 58
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 6 · 2020: 3 · 2019: 10 · 2018: 4 · 2017: 11 · 2016: 9 · 2015: 16 · 2014: 12 · 2013: 11 · 2012: 24
- FWCI
- 8.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by
- Locations
- Journal of Medical Microbiology (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (74898)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, bloodstream infection, invasive candidiasis, Candida albicans, Candida glabrata, Candida parapsilosis, Candida dubliniensis, Candida tropicalis, Candida lusitaniae, fluconazole resistance, antifungal susceptibility, multilocus sequence typing, intensive care unit, abdominal diseases, laparotomy, incidence, Scotland
- MeSH terms
- Adolescent, Adult, Aged, Antifungal Agents, Bacterial Infections, Candida, Candidiasis, Catheters, Indwelling, Child, Child, Preschool, Female, Health Surveys, Humans, Infant, Laparotomy, Male, Microbial Sensitivity Tests, Middle Aged, Prospective Studies, Risk Factors, Scotland, Fluconazole, Incidence, Fungemia, Mycological Typing Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.